Login
Home / 600535.SS : SHH
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Tasly Pharmaceutical Group Co., Ltd

¥13.97 -$1.29 (-8.45%)
SHH · 15 Sep 2026 07:00 UTC
Previous Close
¥14.01
Day Range
¥13.88¥14.07
Year Range
¥12.9¥16.5
Market Cap
20.87B
AVG Volume
14.56M
Trailing/Forward PE
1.56/13.56
PEG ratio
0.09
Dividend Yield
2.22%
Next Earnings Date
2026-10-26
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (CNY)
05B10B15B20B2016201720182019202020212022202320242025
Net Income (CNY)
-1B01B2B3B2016201720182019202020212022202320242025
Operating Income (CNY)
-1B01B2B3B2016201720182019202020212022202320242025
EBITDA (CNY)
01B2B3B4B2016201720182019202020212022202320242025
Cash Flows (CNY)
-2B-1B01B2B3B2016201720182019202020212022202320242025
EPS (CNY)
-0.500.511.522016201720182019202020212022202320242025
Expenses (CNY)
02B4B6B8BR&DSG&ACapex2016201720182019202020212022202320242025
Cash & Debt (CNY)
02.5B5B7.5B10BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
Debt ratios
-0.500.5120182019202020212022202320242025
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
Return on Capital
-5%0%5%10%15%20%2016201720182019202020212022202320242025
Shares Outstanding
0500M1B1.5B2B2016201720182019202020212022202320242025
Dividends (CNY)
00.20.40.60.82017201820192020202120222023202420252026
Book Value Per Share (CNY)
02.557.5102016201720182019202020212022202320242025
Total Assets (CNY)
010B20B30B2016201720182019202020212022202320242025
PE Ratio
17.52022.52527.5med 21.94Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
4%6%8%10%12%med 6.07%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
2.22.42.62.83med 2.67Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
10121416med 12.47Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
6810121416med 11.67Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
1.41.61.822.2med 1.79Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Tasly Pharmaceutical Group Co., Ltd
600535.SS
Stockpicker

Video analysis: 600535.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.